Polymerization products containing amino groups useful in serum cholesterol level control
AssigneePharmacia Aktiebolag
InventorsBjorn G.-A. Ingelman, Bernt J. Lindberg, Jan G. Rosengren, Dag E. S. Campbell
Life of this patent
Estimating the term…
Loading patent…
AssigneePharmacia Aktiebolag
InventorsBjorn G.-A. Ingelman, Bernt J. Lindberg, Jan G. Rosengren, Dag E. S. Campbell
Estimating the term…
A pharmaceutical product containing amino groups, which product: A. is comprised of residues of one or more diamines of the general formula H.sub.2 N.CH.sub.2. phenylene.CH.sub.2.NH.sub.2 (I) which residues are interconnected by bridges between the residues to form a three-dimensional network, the bridges being bound to nitrogen atoms in the residues (I) and comprise straight or branched aliphatic, saturated hydrocarbon chains substituted with one or more hydroxyl groups and containing 3-30 carbon atoms, preferably 3-16 carbon atoms and which are optionally broken by one or more oxygen atoms, the amino groups being present in a free form or in the form of (the cation portion of) a non-toxic salt, and B. is insoluble in water or other solvents, but capable of swelling in water to gel form, 1 g of the dry product in the form of an HCl salt in the presence of water swelling to at least 5 ml and to at most 50 ml, preferably to at least 5 ml and to at most 25 ml, and C. is in grain form having a particle size substantially within the range of 1 to 1000 .mu., preferably 10 to 800 .mu., and D. has an ion-exchange capacity within the range of 0.2 to 1 milliequivalents chloride ions, preferably 0.3 to 0.9 milliequivalents chloride ions, per 100 mg of dry gel, A method for its preparation and use for lowering the cholesterol content of the blood of mammals and birds.
A pharmaceutical product for oral administration to mammals and birds having an elevated serum cholesterol level in their blood, which product contains a physiologically acceptable carrier and a cholesterol lowering amount of a waterinsoluble polymer containing amino groups and which polymer
A pharmaceutical product for oral administration to mammals and birds having an elevated serum cholesterol level in their blood, which product contains a physiologically acceptable carrier and a cholesterol lowering amount of a waterinsoluble polymer containing amino groups and which polymer
A method of lowering the cholesterol content of the blood of mammals and birds having an elevated serum cholesterol level, said method consisting essentially of the oral administration of a physiologically acceptable carrier and a cholesterol lower amount of a polymer containing amino groups and which polymer
A method of lowering the cholesterol content of the blood of mammals and birds having an elevated serum cholesterol level said method consisting essentially of the oral administration of a physiologically active carrier and a cholesterol lowering amount of a polymer containing amino groups and which polymer
Dependencies are inferred from the claim text.